http://bit.ly/2V5TPvq support@endlesssupplies.biz (Endless Supplies .Biz) February 19, 2019 at 04:02AM
Tuesday, February 19, 2019
Teva Pharm expects about 25 pct of EpiPen market by year end
Teva Pharmaceutical Industries expects its generic version of Mylan's EpiPen to have about 25 percent of the U.S. market by the end of 2019, Chief Executive Kare Schultz said on Tuesday.
http://bit.ly/2V5TPvq support@endlesssupplies.biz (Endless Supplies .Biz) February 19, 2019 at 04:02AM
http://bit.ly/2V5TPvq support@endlesssupplies.biz (Endless Supplies .Biz) February 19, 2019 at 04:02AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment